Daily hemodialysis
Maduell, F.
Nefrologia Publicacion Oficial de la Sociedad Espanola Nefrologia 23(4): 291-294
2003
ISSN/ISBN: 0211-6995 PMID: 14558326 Document Number: 556680
Document emailed within 1 workday
Related Documents
Pierratos, A.; McFarlane, P.; Chan, C.T.; Kwok, S.; Nesrallah, G. 2006: Daily hemodialysis 2006. State of the art Minerva Urologica e Nefrologica 58(2): 99-115Newmann, J.M. 2001: Is it time for Medicare to provide reimbursement for daily hemodialysis? Nephrology News and Issues 15(5): 57-59
Ifudu, O. 1999: Daily dialysis in hemodialysis patients with pericardial effusion: where are the data? International Journal of Artificial Organs 22(7): 469-470
Agar, J.W.M. 2007: Should the Medicare ESRD program fund daily and nocturnal hemodialysis? Nephrology News and Issues 21(12): 48 51 54 Passim
Quintaliani, G.; Buoncristiani, U.; Fagugli, R.; Kuluiranu, H.; Ciao, G.; Rondini, L.; Lowenthal, D.T.; Reboldi, G. 2000: Survival of vascular access during daily and three times a week hemodialysis Clinical Nephrology 53(5): 372-377
Brunati, C.; Cassaro, F.; Cretti, L.; Izzo, M.; Pegoraro, M.; Negri, D.; Gervasi, F.; Colussi, G. 2017: Home Daily Hemodialysis with NxStage System One: monocentric italian casistic results Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 34(5): 119-133
Bernard, C.; Beruard, M.; Baur, F.; Lenoir, J.; Jeniń, P. 1980: Application of body impedance measures performed daily in an intensive care and hemodialysis service Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 21(B): 29-34
Yang, A.; Lee, W-ya.; Hocking, K. 2015: Survival comparison of daily home hemodialysis vs. conventional in the nursing home setting Nephrology News and Issues 29(2): 25-7 30-1
Wolf, J.E.; Kerrouche, N.; Arsonnaud, S. 2006: Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea Cutis 77(4 Suppl): 3-11
Karachalios, G.N.; Houpas, P.; Tziviskou, E.; Papalimneou, V.; Georgiou, A.; Karachaliou, I.; Halkiadaki, D. 1998: Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections International Journal of Clinical Pharmacology and Therapeutics 36(10): 561-564
Wasmuth, J.-C.; la Porte, C.J.L.; Schneider, K.; Burger, D.M.; Rockstroh, J.K. 2004: Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR) Antiviral Therapy 9(2): 213-220
Corren, J.; Berkowitz, R.; Murray, J.J.; Prenner, B. 2003: Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma International Journal of Clinical Practice 57(7): 567-572
Thiboutot, D.M.; Fleischer, A.B.; Del Rosso, J.Q.; Graupe, K. 2008: Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea Journal of Drugs in Dermatology: Jdd 7(6): 541-546
Mauracher, E.H.; Lau, W.Y.; Kartowisastro, H.; Ong, K.H.; Genato, V.X.; Limson, B.; Yusi, G.M.; Liu, C.Y.; Suwangool, P. 1989: Comparison of once-daily and thrice-daily netilmicin regimens in serious systemic infections: a multicenter study in six Asian countries Clinical Therapeutics 11(5): 604-613
Horiguchi, S.; Teramoto, K.; Kurono, T.; Ninomiya, K. 1978: The arsenic, copper, lead, manganese and zinc contents of daily foods and beverages in Japan and the estimate of their daily intake Osaka City Medical Journal 24(1): 131-141
Bartoloni, A.; Strohmeyer, M.; Corti, G.; Buonomini, M.I.; Franchino, L.; Romanelli, G.; Moretti, A.M.; De Vizzi, G.B.; Petraglia, A.; Mancini, P.; Atzeni, R.; Fogliani, V.; Giura, R.; Paradisi, F. 1999: Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia Drugs under Experimental and Clinical Research 25(6): 243-252
Wheat, L.J.; Farthing, C.; Cohen, C.; Pierone, G.; Lalezari, J.; Pilson, R.S.; Siemon-Hryczyk, P. 2002: Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection Antiviral Therapy 7(3): 199-209
Ahtoy, P.; Chrétien, P.; Dupain, T.; Rauch, C.; Rouchouse, A.; Delfolie, A. 2002: Alfuzosin, an alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia: once daily versus 3 times daily dosing in healthy subjects International Journal of Clinical Pharmacology and Therapeutics 40(7): 289-294
Zeitoun, P.; Rampal, P.; Barbier, P.; Isal, J.P.; Eriksson, S.; Carlsson, R. 1989: Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium Gastroenterologie Clinique et Biologique 13(5): 457-462
Ndiaye, J.Louis.A.; Faye, B.; Diouf, A.M.; Kuété, T.; Cisse, M.; Seck, P.A.; Brasseur, P.; Same-Ekobo, A.; Lameyre, V.; Gaye, O. 2008: Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria Malaria Journal 7: 16